Cargando…
Frontiers in the pathogenesis of Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by progressive dementia and brain deposits of the amyloid β protein (Aβ) as senile plaques and the microtubule-associated protein, Tau, as neurofibrillary tangles (NFT). The current treatment of AD is limited to drugs that attempt to correct deficits in the...
Autores principales: | Sambamurti, Kumar, Jagannatha Rao, K. S., Pappolla, Miguel A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038543/ https://www.ncbi.nlm.nih.gov/pubmed/21416019 |
Ejemplares similares
-
Nitric Oxide as a Determinant of Human Longevity and Health Span
por: Poeggeler, Burkhard, et al.
Publicado: (2023) -
Tryptophan in Nutrition and Health 2.0
por: Poeggeler, Burkhard, et al.
Publicado: (2023) -
Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy
por: Sampaio, Tuane Bazanella, et al.
Publicado: (2017) -
A Novel Endogenous Indole Protects Rodent Mitochondria and Extends Rotifer Lifespan
por: Poeggeler, Burkhard, et al.
Publicado: (2010) -
The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer’s disease
por: Kim, Dong Kyu, et al.
Publicado: (2019)